Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Rhinitis Seasonal
Interventions
DRUG

fexofenadine HCL (M016455)

Pharmaceutical form:tablet Route of administration: oral

DRUG

pseudoephedrine

"Pharmaceutical form:tablet~Route of administration: oral"

DRUG

fexofenadine HCL matching placebo

"Pharmaceutical form:tablet~Route of administration: oral"

DRUG

pseudoephedrine matching placebo

"Pharmaceutical form:tablet~Route of administration: oral"

Trial Locations (3)

Unknown

Investigational Site Number 392002, Koganeishi

Investigational Site Number 392003, Osaka

Investigational Site Number 392001, Shinjuku-Ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY